Live Breaking News & Updates on Lowering Therapy|Page 1

Stay updated with breaking news from Lowering therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Esperion Announces Positive CLEAR Outcomes Results To Be Presented as Late-Breaking Clinical Trial at ACC.23/WCC

NEXLETOL (bempedoic acid) is the first ATP citrate lyase inhibitor and first oral non-statin to meet the major adverse cardiovascular events (MACE-4) primary endpoint ....

Mphil Cantab , Kausik Ray , Steven Nissen , Sheldon Koenig , Vascular Thoracic Institute At Cleveland Clinic , American College , Annual Scientific Session Together With , World Congress , Late Breaking Clinical Trial , Breaking Clinical Trial Presentation , Bempedoic Acid , Statin Intolerant Patients , High Cardiovascular Risk , Great Hall , Chief Academic Officer , Thoracic Institute , Cleveland Clinic , Expert Theatre , Next Step , Lowering Therapy , Oral Nonstatin Therapies , Late Breaking Clinical Trial Deep Dive , Prescribing Information ,